Stone and Laser Therapies Post-Market Study (SALT)
NCT: NCT06982235 · RECRUITING
NCT IDNCT06982235
StatusRECRUITING
Start Date2025-06-30
Completion2029-02
Brief Summary
The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.
Frequently Asked Questions
What is Stone and Laser Therapies Post-Market Study (SALT)?
Stone and Laser Therapies Post-Market Study (SALT) is a clinical trial registered under NCT06982235. Current status: RECRUITING.
What is the status of NCT06982235?
The current status of NCT06982235 (Stone and Laser Therapies Post-Market Study (SALT)) is: RECRUITING.
When did Stone and Laser Therapies Post-Market Study (SALT) start?
Stone and Laser Therapies Post-Market Study (SALT) started on 2025-06-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.